Jennifer Raab

Special Counsel

Jennifer Raab focuses her practice on the representation of life sciences companies in a wide range of complex strategic transactions, including collaboration agreements, license agreements, co-development and co-promotion agreements, option agreements and manufacturing agreements. She has expertise in both global transactions as well as territory-specific transactions.

Download full bio 


  • Lulu’s – $92 Million IPO 

  • Zai Lab Enters License and Collaboration Agreement with Blueprint Medicines 

  • I-Mab Enters Global Strategic Partnership With AbbVie for Cancer Treatment 

  • Sangamo Announces Global Licensing Collaboration Agreement with Biogen 

  • Jazz Pharma Announces Exclusive License Agreement with PharmaMar 

  • View all


  • University of California, Berkeley School of Law
    JD, 2009

  • University of California, Los Angeles
    BS, with departmental honors, Biochemistry
    departmental honors, 2006


  • California Bar Association